Are you a diabetic,taking multiple types of drugs at the same time? Recent studies have shown that diabetics on average take up to six types of different medications at once and this does not include their diabetic medications. Unfortunately, when these drugs are mixed together many people have extremely bad reactions to them and are often hospitalized.
A large number of common medications that diabetics use, especially high blood pressure medications, can sometimes cause a diabetic condition that would not have existed had the drugs not been taken in the first place.
Below is a list of common drugs and the risks they may have if you are a diabetic:
Beta Blockers: Beta-blockers, such as Lopressor (metoprolol), Tenormin (Atenolol), and Inderal (propanolol), have been known to reduce the release of insulin.
Minoxidil: Minoxidil, a direct vasodilator, has a tendency to raise blood glucose levels.
Thiazide Diuretics: Thiazide diuretics include such drugs as Diuril(Chlorothiazide), Zaroxolyn (Metolazone), and Oretic(Hydrochlorothiazide), and is known to raise glucose levels due to its effect it has on causing the loss of potassium.
Calcium channel blockers: Calcium channel blockers, which are prescribed for Hypertension,management of Angina include such drugs as Calan (Verapamil), Adalat(Nifedipine),and Norvasc(Amlodipine), and is known to reduce the secretion of insulin.
Oral contraceptives: Although current oral contraceptives seem to be safe, the older versions were known to have caused hypoglycemia when estrogen doses were taken at higher than normal doses.
Corticosteroids: Even though corticosteroids can be used as a topical solution, it has a tendency to raise blood glucose levels.
Niacin: Niacin, which is a very common B vitamin and is suggested to lower cholesterol, it has been known to result in a hyperglycemic tendency within a person that has diabetes.
Thyroid hormone: When levels of thyroid hormones are elevated, blood glucose levels are raised because of the reduction of insulin coming from the pancreas.
Diphenylhydantoin: The common name for this drug is called Dilantin which is recommended to people to help control seizures. However, it also blocks the release of insulin.
Wednesday, June 24, 2009
Tuesday, June 23, 2009
Importance of urine microalbumin test for diabetics!!!!
A urine microalbumin test reveals important information about your kidneys.
Healthy kidneys filter waste products from your blood. If your kidneys become damaged, some of these waste products may remain in your blood. At the same time, a type of protein called albumin — which should stay in your blood — leaks into your urine. The microalbumin test detects this protein. Often, an elevated microalbumin level is the first sign of kidney damage.
Regular urine microalbumin tests are often recommended for people who have type 1 or type 2 diabetes. Urine microalbumin tests are also recommended for people who have high blood pressure (hypertension). Both diabetes and high blood pressure can damage the kidneys.
Healthy kidneys filter waste products from your blood. If your kidneys become damaged, some of these waste products may remain in your blood. At the same time, a type of protein called albumin — which should stay in your blood — leaks into your urine. The microalbumin test detects this protein. Often, an elevated microalbumin level is the first sign of kidney damage.
Regular urine microalbumin tests are often recommended for people who have type 1 or type 2 diabetes. Urine microalbumin tests are also recommended for people who have high blood pressure (hypertension). Both diabetes and high blood pressure can damage the kidneys.
Thursday, June 18, 2009
Latest news for Diabetics!!!!
Sudden spike in sugar level sends Testosterone levels down:
A new study has shown that post-meal surges in blood sugar can cut a man’s level of circulating testosterone by about a quarter.
Benefit Of Vitamin D In Diabetes And Other Chronic Diseases:
Vitamin D is quickly becoming the "it" nutrient with health benefits for diseases, including cancer, osteoporosis, heart disease and now diabetes. Recent research in this regards has concluded that adequate intake of vitamin D may prevent or delay the onset of diabetes and reduce complications for those who have already been diagnosed.
Statin Treatment Improves Coronary Circulation in Diabetics :
Statin treatment appears to improve development of coronary collateral circulation in patients with diabetes mellitus and advanced coronary artery disease.
Diabetes drug Victoza shows great promise:
A head-to-head comparison of the experimental diabetes medicine Victoza (liraglutide) and Byetta(exenatide) suggests that the new drug may be better at reducing blood sugar. Researchers found that patients who took Victoza once a day had greater A1c reduction at the end of the 29 week study than patients who took Byetta twice per day. The study of 464 people also found that the nausea side effect produced by both drugs passed three times faster for those taking Victoza. Experts say the new drug shows considerable promise for the treatment of Type 2 diabetes.
A new study has shown that post-meal surges in blood sugar can cut a man’s level of circulating testosterone by about a quarter.
Benefit Of Vitamin D In Diabetes And Other Chronic Diseases:
Vitamin D is quickly becoming the "it" nutrient with health benefits for diseases, including cancer, osteoporosis, heart disease and now diabetes. Recent research in this regards has concluded that adequate intake of vitamin D may prevent or delay the onset of diabetes and reduce complications for those who have already been diagnosed.
Statin Treatment Improves Coronary Circulation in Diabetics :
Statin treatment appears to improve development of coronary collateral circulation in patients with diabetes mellitus and advanced coronary artery disease.
Diabetes drug Victoza shows great promise:
A head-to-head comparison of the experimental diabetes medicine Victoza (liraglutide) and Byetta(exenatide) suggests that the new drug may be better at reducing blood sugar. Researchers found that patients who took Victoza once a day had greater A1c reduction at the end of the 29 week study than patients who took Byetta twice per day. The study of 464 people also found that the nausea side effect produced by both drugs passed three times faster for those taking Victoza. Experts say the new drug shows considerable promise for the treatment of Type 2 diabetes.
Aspirin Therapy for Diabetes
Diabetic patients use different therapies to control the complication of the disorder. Aspirin is one of the most commonly used therapies for diabetic patients. Though the actual effect of aspirin towards diabetes is vague, aspirin therapy is found to be effective, up to certain extent, in diabetic patients.
Aspirin therapies are generally used to control the cardiovascular diseases in diabetic patients. Death rate in diabetic patients is four times more in the patients with cardiovascular diseases. The major cardiovascular diseases associated with a diabetic patient are atherosclerosis, and vascular thrombosis. The reason for rise in cardiovascular diseases in diabetic patients is due to the increased production of thromboxane. This increase in production of thromboxane causes aggregation of platelets in the blood. Due to aggregation of platelets, the circulation of blood is blocked at some parts of the body. Aspirin therapies are given to diabetic patients to impede the process of aggregation of platelets, by acetylating the enzyme cyclo-oxygenage, which helps in the aggregation of platelets.
Experimental analysis have shown that giving a lower dose of aspirin to a diabetic patients with cardiovascular diseases is useful, as a secondary strategy, for lowering cardiovascular diseases. In another study, it was found that giving aspirin therapy, of around 320 mg/day to diabetic patients, is useful in lowering the diabetic cardiovascular disease.
Giving aspirin therapy to a diabetic patient is helpful in preventing diabetic retinopathy. An experimental study about the effect of aspirin on diabetic retinopathy reveals that aspirin therapy may be used as a primary and secondary preventive measure for diabetic retinopathy. Though this mode of therapy is not recommended yet.
In an experimental study of about 20,000 diabetic patients with cardiovascular diseases and myocardial infarction, aspirin therapy is found to be useful in lowering the cardiovascular diseases by 16%, and by 68% with myocardial infarction. Aspirin therapy is useful in diabetic patients who have blood less than 160mmHg.
A dose of 70 mg of enteric-coated aspirin is effective enough to inhibit the synthesis of thromboxane. A lower dose of aspirin is better, as it is more effective with lower dose and also decreases the side effects of the therapy.
If aspirin therapy is used for a long time, it may cause bleeding on the walls of intestine, and may cause gastric mucosal injury. People who use aspirin for a long period may become a victim of hemorrhagic stroke. Use of aspirin also increases bleeding in other parts of body. Use of aspirin therapy has no effect on diabetic retinopathy, it neither improves nor cures in diabetic retinopathy. Use of aspirin may increase the problem of chronic renal diseases and blood pressure in the diabetic patients. Aspirin is not recommended for diabetic patients who are very young.
As always consult with your physician before starting any therapy.
Source:http://www.diabetic-tips.com/aspirin.htm
Aspirin therapies are generally used to control the cardiovascular diseases in diabetic patients. Death rate in diabetic patients is four times more in the patients with cardiovascular diseases. The major cardiovascular diseases associated with a diabetic patient are atherosclerosis, and vascular thrombosis. The reason for rise in cardiovascular diseases in diabetic patients is due to the increased production of thromboxane. This increase in production of thromboxane causes aggregation of platelets in the blood. Due to aggregation of platelets, the circulation of blood is blocked at some parts of the body. Aspirin therapies are given to diabetic patients to impede the process of aggregation of platelets, by acetylating the enzyme cyclo-oxygenage, which helps in the aggregation of platelets.
Experimental analysis have shown that giving a lower dose of aspirin to a diabetic patients with cardiovascular diseases is useful, as a secondary strategy, for lowering cardiovascular diseases. In another study, it was found that giving aspirin therapy, of around 320 mg/day to diabetic patients, is useful in lowering the diabetic cardiovascular disease.
Giving aspirin therapy to a diabetic patient is helpful in preventing diabetic retinopathy. An experimental study about the effect of aspirin on diabetic retinopathy reveals that aspirin therapy may be used as a primary and secondary preventive measure for diabetic retinopathy. Though this mode of therapy is not recommended yet.
In an experimental study of about 20,000 diabetic patients with cardiovascular diseases and myocardial infarction, aspirin therapy is found to be useful in lowering the cardiovascular diseases by 16%, and by 68% with myocardial infarction. Aspirin therapy is useful in diabetic patients who have blood less than 160mmHg.
A dose of 70 mg of enteric-coated aspirin is effective enough to inhibit the synthesis of thromboxane. A lower dose of aspirin is better, as it is more effective with lower dose and also decreases the side effects of the therapy.
If aspirin therapy is used for a long time, it may cause bleeding on the walls of intestine, and may cause gastric mucosal injury. People who use aspirin for a long period may become a victim of hemorrhagic stroke. Use of aspirin also increases bleeding in other parts of body. Use of aspirin therapy has no effect on diabetic retinopathy, it neither improves nor cures in diabetic retinopathy. Use of aspirin may increase the problem of chronic renal diseases and blood pressure in the diabetic patients. Aspirin is not recommended for diabetic patients who are very young.
As always consult with your physician before starting any therapy.
Source:http://www.diabetic-tips.com/aspirin.htm
Wednesday, June 3, 2009
Latest news related to your Heart!!!
Supplement made from Tomatoes may protect against heart disease
Scientists have found that a supplement made from tomatoes may protect against heart disease and strokes when taken daily. The supplement--called Ateronon--contains an active ingredient from the Mediterranean diet, lycopene, which blocks the bad cholesterol that can clog the arteries. In a preliminary trial of 150 patients with heart disease, Ateronon reduced the oxidation of harmful fats in the blood to almost zero within eight weeks. Though the supplement is being launched as a dietary supplement, experts say more trials are needed to determine its effectiveness.
Heart drug combinations linked to GI bleeding
According to new research, common drug combinations used to treat heart disease may increase a patient's risk of developing upper gastrointestinal (GI) tract perforations or bleeding. For the study, investigators looked at data on 78,084 patients from a Department of Veterans Affairs database. About 30 percent were prescribed combinations of two or three drugs to treat heart disease such as anticoagulant-antiplatelet (ACAP), aspirin-antiplatelet (ASAP), aspirin-anticoagulant (ASAC), or TRIP (aspirin-anticoagulant-antiplatelet). The researchers found that patients prescribed TRIP were four times more likely to have an upper GI bleed, while those given ASAP and ASAC drug combinations were two and a half times more likely. The fewest upper GI problems occurred among people taking ACAP.
Scientists have found that a supplement made from tomatoes may protect against heart disease and strokes when taken daily. The supplement--called Ateronon--contains an active ingredient from the Mediterranean diet, lycopene, which blocks the bad cholesterol that can clog the arteries. In a preliminary trial of 150 patients with heart disease, Ateronon reduced the oxidation of harmful fats in the blood to almost zero within eight weeks. Though the supplement is being launched as a dietary supplement, experts say more trials are needed to determine its effectiveness.
Heart drug combinations linked to GI bleeding
According to new research, common drug combinations used to treat heart disease may increase a patient's risk of developing upper gastrointestinal (GI) tract perforations or bleeding. For the study, investigators looked at data on 78,084 patients from a Department of Veterans Affairs database. About 30 percent were prescribed combinations of two or three drugs to treat heart disease such as anticoagulant-antiplatelet (ACAP), aspirin-antiplatelet (ASAP), aspirin-anticoagulant (ASAC), or TRIP (aspirin-anticoagulant-antiplatelet). The researchers found that patients prescribed TRIP were four times more likely to have an upper GI bleed, while those given ASAP and ASAC drug combinations were two and a half times more likely. The fewest upper GI problems occurred among people taking ACAP.
Subscribe to:
Posts (Atom)
